Abl Diagnostics Sa Stock Price To Earning

ABLD Stock   2.40  0.10  4.00%   
AbL Diagnostics SA fundamentals help investors to digest information that contributes to AbL Diagnostics' financial success or failures. It also enables traders to predict the movement of AbL Stock. The fundamental analysis module provides a way to measure AbL Diagnostics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to AbL Diagnostics stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

AbL Diagnostics SA Company Price To Earning Analysis

AbL Diagnostics' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.

P/E

 = 

Market Value Per Share

Earnings Per Share

More About Price To Earning | All Equity Analysis
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
Competition

Based on the latest financial disclosure, AbL Diagnostics SA has a Price To Earning of 0.0 times. This is 100.0% lower than that of the Industrials sector and 100.0% lower than that of the Railroads industry. The price to earning for all France stocks is 100.0% higher than that of the company.

AbL Price To Earning Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses AbL Diagnostics' direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of AbL Diagnostics could also be used in its relative valuation, which is a method of valuing AbL Diagnostics by comparing valuation metrics of similar companies.
AbL Diagnostics is currently under evaluation in price to earning category among its peers.

AbL Fundamentals

About AbL Diagnostics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze AbL Diagnostics SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AbL Diagnostics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AbL Diagnostics SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in AbL Stock

AbL Diagnostics financial ratios help investors to determine whether AbL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AbL with respect to the benefits of owning AbL Diagnostics security.